Tumor suppressor immune gene therapy to reverse immunotherapy resistance

BACKGROUND: While immune checkpoint inhibitors are becoming a standard of care for multiple types of cancer, the majority of patients do not respond to this form of immunotherapy. New approaches are required to overcome resistance to immunotherapies. METHODS: We investigated the effects of adenovira...

Descripción completa

Detalles Bibliográficos
Autores principales: Chada, Sunil, Wiederhold, Dora, Menander, Kerstin B., Sellman, Beatha, Talbott, Max, Nemunaitis, John J., Ahn, Hyo Min, Jung, Bo-Kyeong, Yun, Chae-Ok, Sobol, Robert E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group US 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9209327/
https://www.ncbi.nlm.nih.gov/pubmed/34349241
http://dx.doi.org/10.1038/s41417-021-00369-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9209327/
https://www.ncbi.nlm.nih.gov/pubmed/34349241
http://dx.doi.org/10.1038/s41417-021-00369-7

Ejemplares similares